Scinopharm Taiwan Ltd. (1789)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
20. 10
+0.2
+1.005%
NT$
14.04B Market Cap
- P/E Ratio
- Div Yield
651,302 Volume
- Eps
NT$ 19.9
Previous Close Want to track 1789 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Scinopharm Taiwan Ltd. (1789) Statistics
Valuation metrics
Market Cap 14.04B
Enterprise value 13.33B
Trailing P/E (ttm) 153.05
Forward P/E -
PEG ratio -2.64
Price/Sales (ttm) 5.02
Price/Book (mrq) 1.59
Enterprise Value/Revenue 4.25
Enterprise Value/EBITDA 21.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.07M
Average volume (90 days) 979.76K
Price summary
52-Week low 16.25
52-Week high 29.1
Beta -
50-Day moving average 19.77
200-Day moving average 20.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.35
Trailing annual dividend yield 0.0176%
5-Year annual dividend yield -
Payout ratio 2.58
Dividend Date 24 Jul 2025
Ex-Dividend Date 3 Jul 2025
Last split factor 1,040:1,000
Last split Date 10 Aug 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.03%
Operating margin 0.02%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.8
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 6.55%
Book value per share (mrq) 12.48
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
